무바늘 약물전달 디바이스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Needle-Free Drug Delivery Devices Market size is expected to reach USD 43.45 Billion in 2034 from USD 21.52 Billion (2025) growing at a CAGR of 8.12% during 2026-2034.

The Global Needle-Free Drug Delivery Devices Market has grown significantly due to increasing concerns over needle-stick injuries and patient discomfort associated with traditional injections. Needle-free technologies, including jet injectors and transdermal patches, provide safer and more convenient alternatives for vaccine administration and chronic disease management. Rising vaccination programs and growing preference for minimally invasive procedures have further fueled market expansion.

Major growth drivers include technological advancements in drug delivery systems and the rising prevalence of chronic diseases such as diabetes. Improved patient compliance and reduced risk of cross-contamination enhance the appeal of these devices. Government initiatives promoting immunization and advancements in biologics and self-administration therapies also contribute to increasing demand globally.

Future prospects remain promising as research focuses on expanding applications for biologics and large-molecule drugs. Integration with wearable and smart drug delivery systems may further enhance usability. While high device costs and regulatory challenges may pose barriers, continuous innovation is expected to strengthen adoption and support long-term market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• Inhaler Technology
• Transdermal Patch Technology
• Novel Needle-Free Technologies

By Application

• Vaccine Delivery
• Pain Management
• Insulin Delivery for Diabetes
• Pediatric Injections
• Others

COMPANIES PROFILED

• PenJet, Zealand Pharma, UCB SA, PharmaJet, 3M, Verdict Media Limited, INJEX Pharma AG, Antares Pharma, Endo Pharmaceuticals Inc, Bioject Medical Technologies, Inc, Crossject SA

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Inhaler Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Transdermal Patch Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Novel Needle-Free Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Vaccine Delivery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Insulin Delivery for Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Pediatric Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Technology
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Technology
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Technology
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Technology
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Technology
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 PenJet
  • 8.2.2 Zealand Pharma
  • 8.2.3 UCB S.A
  • 8.2.4 PharmaJet
  • 8.2.5 3M
  • 8.2.6 Verdict Media Limited
  • 8.2.7 INJEX Pharma AG
  • 8.2.8 Antares Pharma
  • 8.2.9 Endo Pharmaceuticals Inc
  • 8.2.10 Bioject Medical TechnologiesInc
  • 8.2.11 Crossject SA